Evolving trends in infective endocarditis

Clinical Microbiology and Infection

Volumn 12, Issue 1, 2006, Pages 5-12

  Hill, E E ^a   Herijgers, P ^a   Herregods, M C ^a   Peetermans, Willy E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cardiac disease; Diagnosis; Endocarditis; Epidemiology; Management; Review; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; DOXYCYCLINE; HYDROXYCHLOROQUINE; LINEZOLID;

ANTICOAGULANT THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EMBOLISM; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; MORTALITY; OUTCOMES RESEARCH; OUTPATIENT CARE; PREDICTION; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS INFECTION; SURGICAL TECHNIQUE; VALVULAR HEART DISEASE;

STAPHYLOCOCCUS;

EID: 33644860486     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01289.x     Document Type: Review

References (58)

1. Barry J, Gump DW. Endocarditis - An overview. Heart Lung 1982; 11: 138-145.
2. Terpenning MS. Infective endocarditis. Clin Geriatr Med 1992; 8: 903-912.
3. Blumenthal J, Wolfson PM, Haspel L, Dunlap S. Infective endocarditis - Current review. J Am Osteopath Assoc 1977; 76: 576-584.
4. Birrer RB, Karl M, Volpe S. Infective endocarditis. J Fam Pract 1987; 24: 289-295.
5. Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363: 139-149.
6. Mylonakis E, Calderwood SB. Medical progress: Infective endocarditis in adults. N Engl J Med 2001; 345: 1318-1330.
7. Nunley DL, Perlman PE. Endocarditis - Changing trends in epidemiology, clinical and microbiologic spectrum. Postgrad Med 1993; 93: 235 - 247.
8. Horstkotte D, Follath F, Gutschik E et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary. Eur Heart J 2004; 25: 267-276.
9. Devlin RK, Andrews MM, von Reyn CF. Recent trends in infective endocarditis: Influence of case definitions. Curr Opin Cardiol 2004; 19: 134-139.
10. Mouly S, Ruimy R, Launay O et al. The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002; 45: 246-256.
11. Ben Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, Siegman-Ingra Y. Hospital-acquired infective endocarditis: Should the definition be broadened? Clin Infect Dis 2004; 38: 843-850.
12. Haddad SH, Arabi YM, Memish ZA, Al Shimemeri AA. Nosocomial infective endocarditis in critically ill patients: A report of three cases and review of the literature. Int J Infect Dis 2004; 8: 210-216.
13. Fefer P, Raveh D, Rudensky B, Schlesinger Y, Yinnon AM. Changing epidemiology of infective endocarditis. a retrospective survey of 108 cases, 1990-99. Eur J Clin Microbiol Infect Dis 2002; 21: 432-437.
14. Cabell CH, Jollis JG, Peterson GE et-al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002; 162: 90-94.
15. Loupa C, Mavroidi N, Boutsikakis I et al. Infective endocarditis in Greece: A changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect 2004; 10: 556-561.
16. Hoen B, Alla F, Selton-Suty C, Beguinot I et al. Changing profile of infective endocarditis - Results of a 1-year survey in France. JAMA 2002; 288: 75-81.
17. Cecchi E, Forno D, Imazio M, et al. New trends in the epidemiological and clinical features of infective endocarditis: Results of a multicenter prospective study Ital Heart J 2004: 5: 249-256
18. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults - risk classification for mortality. JAMA 2003; 289: 1933-1940.
19. Hamza N, Ortiz J, Bonomo RA. Isolated pulmonic valve infective endocarditis: A persistent challenge. Infection 2004; 32: 170 - 175.
20. Morris AJ, Drinkovic D, Pottumarthy S et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis 2003; 36: 697-704.
21. Chu VH, Cabell CH, Benjamin DK et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109: 1745-1749.
22. Langiulli M, Salomon P, Aronow WS, McClung JA, Belkin RN. Comparison of outcomes in patients with active infective endocarditis with versus without paravalvular abscess and with and without valve replacement. Am J Cardiol 2004; 94: 136-137.
23. Cabell CH, Pond KK, Peterson GE et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001; 142: 75-80.
24. Lamas CC, Eykyn SJ. Blood culture negative endocarditis. analysis of 63 cases presenting over 25 years. Heart 2003; 89: 258-262.
25. Barrau K, Boulamery A, Imbert G et al. Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect 2004; 10: 302-308.
26. Podglajen I, Bellery F, Poyart C et al. Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 2003; 9: 1543-1547.
27. Deprele C, Berthelot P, Lemetayer F et al. Risk factors for systemic emboli in infective endocarditis. Clin Microbiol Infect 2004; 10: 46-53.
28. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis. clinical predictors of outcome. Heart 2002; 88: 53-60.
29. Granowitz EV, Longworth DL. Risk stratification and bedside prognostication in infective endocarditis. JAMA 2003: 289: 1991-1993
30. De Castro S, Magni G, Beni S et al. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997; 80: 1030-1034.
31. Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of culture-negative endocarditis. Medicine 2003; 82: 263-273.
32. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 220-222.
33. Hoen B, Beguinot I, Rabaud C et al. The Duke criteria for diagnosing infective endocarditis are specific: Analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis 1996; 23: 298-302.
34. Hoen B, Seltonsuty C, Danchin N et al. Evaluation of the Duke Criteria versus the Beth-Israel Criteria for the diagnosis of infective endocarditis. Clin Infect Dis 1995; 21: 905-909.
35. Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 1996; 77: 403-407.
36. Andres E, Baudoux C, Noel E, Goichot B, Schlienger JL, Blickle JF. The value of the Von Reyn and the Duke diagnostic criteria for infective endocarditis in internal medicine practice. A study of 38 cases. Eur J Intern Med 2003; 14: 411-414.
37. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
38. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001; 14: 177-207.
39. Bosshard PP, Kronenberg A, Zbinden R, Ruef C, Bottger EC, Altwegg M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: A 3-year experience. Clin Infect Dis 2003; 37: 167-172.
40. Lang S, Watkin RW, Lambert PA, Bonser RS, Littler WA, Elliott TSJ. Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect 2004; 48: 269-275.
41. Millar BC, Moore JE. Emerging issues in infective endocarditis. Emerg Infect Dis 2004; 10: 1110-1116.
42. Bayer AS, Bolger AF, Taubert KA et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98: 2936-2948.
43. Wilson WR, Karchmer AW, Dajani AS et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274: 1706-1713.
44. Verhagen DWFM, Plokker HW, Buiting AG, Tjoeng MM, van der Meer JT. Optimisation of the antibiotic guidelines in The Netherlands. VII. SWAB guidelines for antimicrobial therapy in adult patients with infectious endocarditis. Neth J Med 2003; 61: 421-429.
45. Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 2001; 32: 1373-1375.
46. Zimmer SM, Caliendo AM, Thigpen MC, Somani J. Failure of linezolid treatment for enterococcal endocarditis. Clin Infect Dis 2003; 37: E29-E30.
47. Leung KT, Tong MKH, Siu YP, Lam CS, Ng HL, Lee HK. Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid. Scand J Infect Dis 2004; 36: 483-485.
48. Howden BP, Ward PB, Charles PGP et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521-528.
49. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program. Clin Infect Dis 2003; 36: 159-168.
50. Raoult D, Houpikian P, Dupont HT, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis - Comparison of two regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999; 159: 167-173.
51. Netzer ROM, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C. Infective endocarditis: Determinants of long term outcome. Heart 2002; 88: 61-66.
52. Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in non-addicts changing? Eur Heart J 1995; 16: 1686-1691.
53. Bishara J, Leibovici L, Gartman-Israel D et al. Long-term outcome of infective endocarditis: The impact of early surgical intervention. Clin Infect Dis 2001; 33: 1636-1643.
54. Remadi JP, Najdi G, Brahim A, Coviaux F, Majhoub Y, Tribouilloy C. Superiority of surgical versus medical treatment in patients with Staphylococcus aureus infective endocarditis. Int J Cardiol 2005; 99: 195-199.
55. Chirouze C, Cabell CH, Fowler VG et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the international collaboration on endocarditis merged database. Clin Infect Dis 2004; 38: 1323-1327.
56. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis - A propensity analysis. JAMA 2003; 290: 3207-3214.
57. Castillo JC, Anguita MP, Torres F et al. Long-term prognosis of early and late prosthetic valve endocarditis. Am J Cardiol 2004; 93: 1185-1187.
58. Chang FY, Peacock JE, Musher DM et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 2003; 82: 333-339.